Free Trial

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies logo
$83.02 +1.18 (+1.44%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$83.06 +0.04 (+0.05%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
11
Buy
12

Based on 23 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 23 analysts, 11 have given a hold rating, and 12 have given a buy rating for GEHC.

Consensus Price Target

$82.17
-1.02% Downside
According to the 23 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $82.17. The highest price target for GEHC is $110.00, while the lowest price target for GEHC is $14.00. The average price target represents a forecasted downside of -1.02% from the current price of $83.02.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GEHC Analyst Ratings Over Time

TypeCurrent Forecast
11/14/25 to 11/14/26
1 Month Ago
10/15/25 to 10/15/26
3 Months Ago
8/16/25 to 8/16/26
1 Year Ago
11/14/24 to 11/14/25
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
11 Buy rating(s)
10 Buy rating(s)
6 Buy rating(s)
Hold
11 Hold rating(s)
10 Hold rating(s)
11 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$82.17$78.35$77.73$86.10
Forecasted Upside-1.02% Downside11.37% Upside5.48% Upside17.70% Upside
Consensus RatingModerate BuyModerate BuyHoldModerate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

GE HealthCare Technologies Stock vs. The Competition

TypeGE HealthCare TechnologiesHealthcare CompaniesBroader Market
Consensus Rating Score
2.52
2.32
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside-1.02% Downside115.11% Upside14.68% Upside
News Sentiment Rating
Positive News

See Recent GEHC News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
11/11/2026
Argus logo
Argus
3 of 5 stars
David Toung
4 of 5 stars
Boost TargetBuy$85.00 ➝ $110.00+32.60%
11/3/2026
UBS Group AG logo
UBS Group
4 of 5 stars
Graham Doyle
Not Rated
Boost TargetNeutral$73.00 ➝ $80.00-0.48%
10/29/2026
Citigroup Inc. logo
Citigroup
4 of 5 stars
Joanne Wuensch
Joanne Wuensch
3 of 5 stars
Boost TargetNeutral$71.00 ➝ $79.00+4.19%
10/29/2026Boost TargetOverweight$85.00 ➝ $95.00+25.30%
10/29/2026 Reiterated RatingNeutral
10/29/2026Boost TargetNeutral$70.00 ➝ $80.00+4.68%
10/29/2026Boost TargetOutperform$80.00 ➝ $90.00+17.64%
10/28/2026Boost TargetBuy$75.00 ➝ $83.00+7.92%
10/20/2026 Initiated CoveragePeer Perform
10/6/2026 UpgradeHold (C-) ➝ Hold (C)
10/5/2026Reiterated RatingBuy$93.00+43.11%
8/11/2026 UpgradeStrong Sell ➝ Hold
7/30/2026 Reiterated RatingOutperform$84.00+21.58%
7/30/2026Reiterated RatingOutperform
7/30/2026Boost TargetOverweight$75.00 ➝ $85.00+22.84%
7/29/2026Reiterated RatingBuy
7/17/2026 Initiated CoverageMarket Perform$14.00-77.87%
7/8/2026 Initiated CoverageMarket Perform$70.00+8.23%
6/8/2026Reiterated RatingNeutral
5/1/2026 Lower Target$95.00 ➝ $88.00+44.24%
4/30/2026Lower Target$90.00 ➝ $80.00+32.31%
4/30/2026 Lower Target$100.00 ➝ $90.00+47.52%
4/30/2026 Lower Target$105.00 ➝ $90.00+47.52%
4/30/2026 Lower Target$110.00 ➝ $98.00+60.63%
4/29/2026 Set Target$80.00+34.24%
2/4/2026Boost TargetEqual Weight$80.00 ➝ $85.00+2.93%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:36 PM ET.


Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, November 11, 2026. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

  • GE HealthCare Technologies Inc. recently raised its full-year 2026 organic revenue guidance to 4%, signaling strong operational momentum and confidence in its ability to drive growth despite macroeconomic headwinds.
  • The company's equipment backlog grew 12% year over year to $23.7 billion, indicating robust future revenue visibility and sustained demand for its medical imaging and patient care solutions.
  • GE HealthCare Technologies Inc. reported third-quarter earnings of $1.34 per share, significantly beating the analyst consensus estimate of $1.20, which demonstrates strong profitability and effective cost management.
  • With the current stock price at $82.60, the company offers a compelling valuation with a P/E ratio of 17.07, which is attractive for investors seeking exposure to the healthcare technology sector at a reasonable multiple.
  • Recent product innovations, such as the launch of Allia Celeo for interventional imaging and the expansion of Vscan Air AI capabilities, position the company as a leader in integrating artificial intelligence into clinical diagnostics.

GE HealthCare Technologies
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

  • Despite strong recent results, the company faces ongoing margin pressures and tariff risks that could impact profitability, as highlighted in recent earnings call discussions regarding fourth-quarter growth concerns.
  • Short interest in GE HealthCare Technologies Inc. has increased in recent months, with the most recent data showing a rise in shares shorted, which may indicate bearish sentiment among some market participants.
  • The stock has experienced volatility, including a recent decline of 1.05 points to $82.60, reflecting potential market uncertainty or broader sector adjustments that could affect investor returns.
  • While the company has strong institutional ownership, some large investors have recently reduced their positions, such as Sumitomo Mitsui Trust Group Inc. trimming its stake by 4.5% in the third quarter, which could signal a lack of confidence in near-term performance.
  • The company's debt-to-equity ratio of 0.86 and current ratio of 1.30 suggest that while it is financially stable, it carries a moderate level of leverage that could limit its flexibility in a challenging economic environment.

GEHC Forecast - Frequently Asked Questions

According to the research reports of 23 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $82.17, with a high forecast of $110.00 and a low forecast of $14.00.

23 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last twelve months. There are currently 11 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" GEHC shares.

According to analysts, GE HealthCare Technologies's stock has a predicted downside of -1.02% based on their 12-month stock forecasts.

Over the previous 90 days, GE HealthCare Technologies's stock had 2 upgrades by analysts.

GE HealthCare Technologies has been rated by research analysts at Argus, Bank of America, Barclays, BTIG Research, Citigroup, JPMorgan Chase & Co., Needham & Company LLC, Royal Bank Of Canada, UBS Group, Weiss Ratings, and Wolfe Research in the past 90 days.

Analysts like GE HealthCare Technologies more than other "healthcare" companies. The consensus rating for GE HealthCare Technologies is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how GEHC compares to other companies.


MarketBeat monitors more than a dozen sources for GE HealthCare Technologies analyst ratings, with the most recent rating issued on 11/11/2026.
From Our Partners